Clinical Trials on Preload-responsiveness in Australia
Total 1 results
-
Medical University of ViennaCompletedVaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization TreatmentAustria
Sponsors and Collaborators
- Phramongkutklao College of Medicine and Hospital
- Alessandra Palo
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Gregorio Covino
- EMET Pharmaceuticals, LLC
- Eastman Kodak Company
- Grünenthal Denmark ApS
- Saint Pierre Institute - Palavas les Flots
- Irish Endocrine Society
- Axon Neuroscience SE
- Yancheng City NO.1 People's Hospital
- CeRSM
- Doterra Healing Hands Foundation
- Department of Anesthesiology, North Denmark Regional Hospital
- Invicta Medical Inc.
- CARITAS Rundum zu Hause betreut
- Erzurum Regional Training & Research Hospital
- YASEMİN AYDIN KARTAL
- Outpatient Endovascular and Interventional Society
- Aga Khan Foundation, Pakistan
- View Full List
Medical Conditions
- Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
- Modality of Discharge Instructions
- Central Motor Disorders
- Mineralocorticoid Excess
- Chondrosis
- Hypogonadism, Hypogonadotropic
- Neutrophilia Acute
- Hemopathies
- Skeletal Muscle Energy Metabolism
- Venous Puncture
- Abdominal Compartment Syndrome
- Ferritin Threshold
- Bioequivalence, AUC, Cmax, Pharmacokinetics
- Osteopathic Manipulative Treatment
- Acute Endophthalmitis Post-operative
- Reading Disability
- Pelvic and Groin Areas Biopsy
- HIV Pre-exposure Prophylaxis Use
- Major Depressive Disorder, Recurrent Episode, Severe
- Human Risk Factors
- View Full List
Drug Interventions
- Pregabalin
- Carbetocin
- Pacritinib
- Systemic intravenous lidocaine infusion
- Betamethasone
- Risperidone
- Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
- Test varnish
- Niraparib
- Lenalidomide
- Neridronate
- Anti-PD1 antibody, nimotuzumab and capecitabine
- Amantadine Sulfate
- Naltrexone 50 Mg + Inactive Marijuana (0% THC)
- Leuprolide acetate 11.25 mg
- Enteral oxygen therapy
- MYL-1501D product using manufacture process VI
- LY2216684
- Apatinib
- Ranitidine
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Colombia
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Finland
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Kenya
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Singapore
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Switzerland
- CRO list by country